login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
XERIS BIOPHARMA HOLDINGS INC (XERS) Stock News
USA
- NASDAQ:XERS -
US98422E1038
-
Common Stock
9.21
USD
+0.08 (+0.88%)
Last: 10/24/2025, 8:02:42 PM
9.21
USD
0 (0%)
After Hours:
10/24/2025, 8:02:42 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
XERS Latest News, Press Relases and Analysis
All
Press Releases
2 days ago - By: Xeris Biopharma Holdings, Inc.
Xeris Biopharma to Report Third Quarter 2025 Financial Results on November 6, 2025
4 days ago - By: Zacks Investment Research
Are You Looking for a Top Momentum Pick? Why Xeris Biopharma (XERS) is a Great Choice
5 days ago - By: Zacks Investment Research
- Mentions:
IRWD
Xeris Biopharma Holdings, Inc. (XERS) Hit a 52 Week High, Can the Run Continue?
12 days ago - By: Zacks Investment Research
- Mentions:
UNH
DGX
MU
TMO
...
Beat the Market the Zacks Way: MariMed, Xeris Biopharma, Lam Research in Focus
21 days ago - By: Xeris Biopharma Holdings, Inc.
Xeris Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2 months ago - By: Zacks Investment Research
What Makes Xeris Biopharma (XERS) a Strong Momentum Stock: Buy Now?
3 months ago - By: The Motley Fool
Xeris (XERS) Q2 Revenue Jumps 49%
2 months ago - By: Yahoo Finance
Xeris Biopharma Holdings, Inc. (XERS) Reports Record $71.5M Q2 Revenue
2 months ago - By: American Regent, Inc.
American Regent® Launches Gvoke VialDx™ (glucagon injection)
2 months ago - By: Xeris Biopharma Holdings, Inc.
Xeris Announces Orange Book Listing of U.S. Patent for Recorlev®
2 months ago - By: Zacks Investment Research
Xeris Biopharma (XERS) Upgraded to Buy: Here's Why
3 months ago - By: Benzinga
- Mentions:
GSAT
PGY
ADV
REAL
...
Earnings Scheduled For August 7, 2025
6 months ago - By: Benzinga
- Mentions:
MSC
ELUT
ACIW
JYNT
...
Earnings Scheduled For May 8, 2025
2 months ago - By: Zacks Investment Research
- Mentions:
RIGL
Xeris Biopharma Holdings, Inc. (XERS) Hits Fresh High: Is There Still Room to Run?
3 months ago - By: Zacks Investment Research
Xeris Biopharma (XERS) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
3 months ago - By: Zacks Investment Research
- Mentions:
MGX
Xeris Biopharma (XERS) Reports Q2 Loss, Tops Revenue Estimates
3 months ago - By: Xeris Biopharma Holdings, Inc.
Xeris Biopharma Reports Record Financial Results for the Second Quarter 2025 and Raises Full Year Revenue Guidance
3 months ago - By: Xeris Biopharma Holdings, Inc.
Xeris Biopharma to Report Second Quarter 2025 Financial Results on August 7, 2025
5 months ago - By: Xeris Biopharma Holdings, Inc.
Xeris Unveils Strategy for Long-Term Growth and Value Creation at 2025 Analyst & Investor Day
5 months ago - By: Xeris Biopharma Holdings, Inc.
Xeris Announces Details for Analyst & Investor Day
6 months ago - By: Yahoo Finance
- Mentions:
BLK
BEN
ANAB
COMP
...
Xeris Biopharma Holdings, Inc. (XERS): Among the Unstoppable Growth Stocks to Invest in Now
6 months ago - By: Zacks Investment Research
- Mentions:
ZVRA
Xeris Biopharma (XERS) Reports Q1 Loss, Tops Revenue Estimates
6 months ago - By: Xeris Biopharma Holdings, Inc.
Xeris Biopharma Reports Record First Quarter 2025 Financial Results
6 months ago - By: Zacks Investment Research
- Mentions:
CORT
Corcept Therapeutics (CORT) Meets Q1 Earnings Estimates
6 months ago - By: Xeris Biopharma Holdings, Inc.
Xeris Biopharma to Report First Quarter 2025 Financial Results on May 8, 2025
6 months ago - By: Yahoo Finance
- Mentions:
PSNL
FUBO
MP
CHPT
...
Is Personalis, Inc. (PSNL) the Best Multibagger Penny Stock to Buy According to Billionaires?
6 months ago - By: Yahoo Finance
- Mentions:
FUBO
QS
PSNL
CNC
...
Is Fubotv Inc. (FUBO) the Best Multibagger Penny Stock to Buy According to Billionaires?
6 months ago - By: Yahoo Finance
- Mentions:
COMM
VRTX
CNC
MP
...
Is CommScope Holding Company, Inc. (COMM) the Best Multibagger Penny Stock to Buy According to Billionaires?
6 months ago - By: Yahoo Finance
- Mentions:
LUMN
VRTX
CNC
COMM
...
Is Lumen Technologies, Inc. (LUMN) the Best Multibagger Penny Stock to Buy According to Billionaires?
6 months ago - By: Yahoo Finance
- Mentions:
CVS
UNH
VRTX
COMM
...
Jim Cramer on CVS Health (CVS): “CVS Is the Best… the Last One Standing”
6 months ago - By: Yahoo Finance
- Mentions:
TSLA
CNC
VRTX
COMM
...
GraniteShares Launches New Leveraged, Single-Stock EV ETFs
6 months ago - By: Yahoo Finance
- Mentions:
SHOP
CNC
COMM
VRTX
...
Jim Cramer on Shopify (SHOP): “De Minimis Will Sort Itself Out”
6 months ago - By: Yahoo Finance
- Mentions:
CSX
TM
COMM
VRTX
...
Jim Cramer on CSX Corp (CSX): “There Is an Element of Forgiveness Today”
6 months ago - By: Yahoo Finance
- Mentions:
PLUG
COMM
TSLA
VRTX
Plug Power Inc. (PLUG): Among EV Penny Stock From $10 to Under $1
6 months ago - By: Yahoo Finance
- Mentions:
TSLA
CHPT
NIO
ACHR
...
3 No-Brainer EV Stocks to Buy With $100 Right Now
Please enable JavaScript to continue using this application.